Thursday, 4 November 2021

Aim 2021

 The strength of the market surprised even Marcus Stuttard, head of Aim and UK primary markets at the London Stock Exchange (LSE). Aim’s performance shows it has been “remarkably resilient” and “investors have been looking to Aim for performance and access to growth” over the pandemic period. At the same time, strong primary and secondary market issuance shows both companies and investors, including plenty of non-UK companies, remain attracted to London's junior market. “52 per cent of the total capital raised on European growth markets so far this year has been raised on Aim, demonstrating the depth and maturity of the market," notes Stuttard.

It has been a very active year for IPOs. Major floats include Revolution Beauty (REVB), which raised £300m in July, while the third quarter of 2021 was record-breaking: the period saw 19 Aim floats raise £1.1bn, against just £76m in the same three months in 2020. This reflected improved market confidence in the economic outlook, as the success of the vaccine rollout and removal of the most stringent pandemic restrictions allowed the resumption of relatively normal trading conditions for businesses.

While the volume of IPOs suggests Aim is succeeding in attracting high-growth capital to the market, this doesn’t tell the whole story. Extremely loose monetary policy from governments around the world since the pandemic hit has diverted even more cash into the market, driving up stock values. The number of flotations is another sign of this. Overvaluations, as demonstrated by several notable stocks that have plunged shortly after listing, remain a perennial issue for a bourse full of high-growth, big-promise stories.

Could this soon change? The competitiveness and regulatory frameworks of the London exchanges has been much discussed in the past year. Lord Hill’s listing review set out several recommendations, including an overhaul of the prospectus regime. Stuttard says the market has a “tried and tested regulatory model that has stood the test of time” but the LSE will support prospectus reform that benefits retail investors. Dr Paul Jourdan, chief executive of Amati Global Investors, thinks new stock exchange entrants could help to keep costs down and remove monopolistic tendencies. “The best way of improving Aim would be competition," he argues, and referenced subscription-based Acquis Exchange as one rival that could gather steam in the coming years.

A higher tax environment could also be seen as a risk to the market. It is not outlandish to think that the tax privileges that Aim enjoys – such as entrepreneurs’ relief, business relief (BR) and VCT exemptions – could be threatened in the future. But while investors and managers should keep this in mind, unpicking a tax relief such as BR, designed to shelter businesses through the succession process, would not be a straightforward task.

Aim has outperformed expectations over the past 18 months. Whether this can be maintained is another question. Fundamentals remain strong and the IPO pipeline looks robust, but high-growth stocks are just as affected by the inflation and labour shortages that currently dog larger corporates. These themes, and plenty more besides, are wrapped in the 50 briefings that follow.

In the second part of this feature, which will appear in in a fortnight's time in the issue dated 19 November, we'll be assessing the strengths and weaknesses of the top 50 largest Aim constituents.

Aim 100: 100-91

Aim 100: 90-81

Aim 100: 80-71

Aim 100: 70-61

Aim 100: 60-51

 

Aim 100 Part 1
NumberNameCodeMarket Cap (£m)Price (£)Fwd PE1-yr simple return (%)1-yr total return (%)Sector2020 ranking
100NovacytNCYT177.52.5136.1-77.2-77.2Biotechnology-
99Proton Motor Power SystemsPPS340.70.44--23.5-23.5Electrical Products-
98Frp AdvisoryFRP285.01.2717.822.727.0Miscellaneous Commercial Services-
97Pan African ResourcesPAF281.60.17365.1-13.2-10.4Precious Metals74
96Creo MedicalCREO298.51.65-7.97.9Medical Specialties81
95Avacta GroupAVCT305.21.224--25.8-25.8Miscellaneous Commercial Services-
94IdoxIDOX315.60.71434.538.939.6Packaged Software-
93Gooch & HousegoGHH313.012.533.313.914.3Electronic Components79
92Knights GroupKGH325.53.918.6-2.5-2.5Miscellaneous Commercial Services55
91Jadestone EnergyJSE403.60.8727.874.077.0Integrated Oil85
90Seeing MachinesSEE368.10.097-114.4114.4Electronic Equipment/Instruments-
89Ekf DiagnosticsEKF373.90.80622.324.025.7Medical Specialties-
88IQEIQE364.60.4545167.8-15.8-15.8Semiconductors58
87Brooks MacdonaldBRK408.926.2515.061.365.8Investment Managers68
86AFC EnergyAFC440.70.6-246.8246.8Electrical Products-
85Alpha FinancialAFM389.73.4821.064.968.7Miscellaneous Commercial Services96
84Numis CorporationNUM354.53.417.515.619.6Investment Banks/Brokers78
83Jubilee Metals GroupJLP407.00.1675-146.3146.3Precious Metals-
82Inspecs GroupSPEC395.03.932.8119.7119.7Financial Conglomerates-
81AB DynamicsABDP423.018.748.0-13.0-12.8Auto Parts: OEM65
80Central Asia MetalsCAML448.92.557.449.864.9Other Metals/Minerals71
79Benchmark HoldingsBMK414.00.6175-28.628.6Pharmaceuticals: Major83
78Atalaya MiningATYM539.03.95.3119.1119.1Precious Metals95
77Judges ScientificJDG491.477.835.349.650.9Electronic Equipment/Instruments57
76MP EvansMPE470.48.612.056.461.8Agricultural Commodities/Milling62
75Revolution BeautyREVB374.81.2148.1--Financial Conglomerates-
74IG Design GroupIGR270.92.811.2-36.2-35.2Consumer Sundries30
73Randall & QuilterRQIH502.31.82518.35.89.4Specialty Insurance59
72Silence TherapeuticsSLN449.85.01-30.130.1Miscellaneous Commercial Services41
71IenergizerIBPO530.52.79-30.536.8Data Processing Services-
70RenalytixRENX640.18.86-92.692.6Packaged Software-
69NicholsNICL426.511.5528.014.415.9Beverages: Non-Alcoholic32
68TinybuildTBLD401.01.9839.7--Packaged Software-
67Hotel ChocolatHOTC702.25.1240.938.438.4Food: Specialty/Candy52
66FW ThorpeTFW491.54.2-35.037.5Electrical Products54
65Young & CoYNGA897.615.3529.079.379.3Beverages: Alcoholic36
64Midwich GroupMIDW590.66.729.988.790.9Wholesale Distributors43
63Naked WinesWINE499.46.8-41.141.1Beverages: Alcoholic-
62Serica EnergySQZ639.82.3855.0122.9129.0Oil Refining/Marketing77
61Amryt PharmaAMYT503.91.59--22.8-22.8Pharmaceuticals: Major-
60Alliance PharmaAPH552.51.0318.437.339.8Pharmaceuticals: Other47
59Urban Logistics ReitSHED558.91.7222.422.425.7Real Estate Investment Trusts-
58BokuBOKU554.51.87566.758.258.2Miscellaneous Commercial Services-
57Watkin JonesWJG604.52.3615.467.475.9Homebuilding38
56Advanced Medical SolutionsAMS702.13.2634.745.546.4Medical Specialties28
55Renew HoldingsRNWH598.07.615.065.269.1Engineering & Construction50
54Greatland GoldGGP697.80.176--27.4-27.4Precious Metals-
53Eurasia MiningEUA610.70.214--28.1-28.1Metal Fabrication-
52Warehouse ReitWHR696.81.6421.951.958.9Real Estate Investment Trusts75
51RestoreRST651.94.7722.147.247.9Other Transportation33
Source: FactSet, LSE. Aim 100 ranking as of 23 Sep 2021, price data accurate as of 27 Oct

No comments:

Post a Comment